Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CGON · NASDAQ · Biological Products, (No Diagnostic Substances)
$79.47−2.43 (−2.97%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Cg Oncology (CGON) · oqro.io/stocks/CGON · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 18, 2026 · Filed Nov 18, 2026
CEO purchased ~$2.37M of CGON shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 18, 2026
Officer purchased ~$299K of CGON shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 17, 2026
Director sold ~$92K of CGON shares in the open marketSourceInsider trade · Traded Oct 15, 2026 · Filed Oct 19, 2026
Director sold ~$31K of CGON shares in the open marketSourceInsider trade · Traded Oct 15, 2026 · Filed Oct 19, 2026
Director sold ~$31K of CGON shares in the open marketSourcePlanned sale · Planned for Oct 15, 2026 · Notice filed Oct 15, 2026
Director filed to sell about $186K of CGON stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
RTW Investments, LP disclosed an increased position in CGON for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed a new position in CGON for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC no longer reported CGON for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in CGON for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
RTW Investments, LP disclosed an increased position in CGON for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Driehaus Capital Management LLC disclosed a new position in CGON for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in CGON for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Eventide Asset Management, LLC disclosed an increased position in CGON for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a reduced position in CGON for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP disclosed an increased position in CGON for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. no longer reported CGON for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed a reduced position in CGON for Q3 2025SourceInsider trade · Traded Sep 29, 2025 · Filed Sep 30, 2025
Director sold ~$500K of CGON shares in the open marketSourceInsider trade · Traded Sep 18, 2025 · Filed Sep 22, 2025
Director sold ~$746K of CGON shares in the open marketSourceInsider trade · Traded Sep 19, 2025 · Filed Sep 22, 2025
Director sold ~$139K of CGON shares in the open marketSourceInsider trade · Traded Sep 15, 2025 · Filed Sep 16, 2025
Director sold ~$35K of CGON shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deerfield Management Company, L.P. no longer reported CGON for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed a reduced position in CGON for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC no longer reported CGON for Q1 2025SourceInsider trade · Traded Jul 17, 2025 · Filed Jul 18, 2025
Director sold ~$56K of CGON shares in the open marketSourceInsider trade · Traded May 21, 2025 · Filed May 22, 2025
Director sold ~$28K of CGON shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Orbimed Advisors LLC disclosed an increased position in CGON for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Avoro Capital Advisors LLC no longer reported CGON for Q1 2025SourceInsider trade · Traded Apr 28, 2025 · Filed Apr 29, 2025
Director sold ~$31K of CGON shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 18, 2025
Director sold ~$28K of CGON shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Director sold ~$29K of CGON shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed an increased position in CGON for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. no longer reported CGON for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
RTW Investments, LP disclosed an increased position in CGON for Q4 2024Insider trade · Traded Jan 13, 2025 · Filed Jan 14, 2025
Director sold ~$30K of CGON shares in the open marketSourceInsider trade · Traded Dec 16, 2024 · Filed Dec 17, 2024
Director sold ~$19.6M of CGON shares in the open marketSourceInsider trade · Traded Dec 16, 2024 · Filed Dec 17, 2024
Director sold ~$29K of CGON shares in the open marketSourceInsider trade · Traded Dec 6, 2024 · Filed Dec 6, 2024
Director sold ~$26K of CGON shares in the open marketSourceInsider trade · Traded Dec 6, 2024 · Filed Dec 6, 2024
Director sold ~$8.7K of CGON shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed a new position in CGON for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deerfield Management Company, L.P. disclosed an increased position in CGON for Q3 2024SourceInsider trade · Traded Sep 11, 2025 · Filed Sep 15, 2025
Director purchased ~$50M of CGON shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Director sold ~$376K of CGON shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Director sold ~$244K of CGON shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Director sold ~$129K of CGON shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Director sold ~$103K of CGON shares in the open marketSourceInsider trade · Traded Sep 3, 2025 · Filed Sep 4, 2025
Director sold ~$1.92M of CGON shares in the open marketSourceInsider trade · Traded Sep 3, 2025 · Filed Sep 4, 2025
Director sold ~$850K of CGON shares in the open marketSourceInsider trade · Traded Sep 3, 2025 · Filed Sep 4, 2025
Director sold ~$28K of CGON shares in the open marketSourceInsider trade · Traded Sep 3, 2025 · Filed Sep 4, 2025
Director sold ~$2.9K of CGON shares in the open marketSourceInsider trade · Traded Sep 3, 2025 · Filed Sep 4, 2025
Director sold ~$2.9K of CGON shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in CGON for Q4 2024Source